Philip Bonomi
- Oncology top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 5%
- Epidemiology
- Cancer Research
- Co-authors
- Sari H. EnschedeCharles M. RudinGeoffrey I. ShapiroD. GandaraAndrew KrivoshikPhilip M. HemkenChristine L. HannDivis Khaira
- Topics
- Lung Cancer Treatments and Mutations (14 papers)Lung Cancer Research Studies (13 papers)Cancer Treatment and Pharmacology (6 papers)
- Journals
- Journal of Clinical OncologyCancerInternational Journal of Radiation Oncology*Biology*Physics
- Partner nations
- United StatesUnited KingdomIreland
In The Last Decade
Philip Bonomi
36 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 78
- Oncology 593
- Molecular Biology 592
- Pulmonary and Respiratory Medicine 403
- Epidemiology 140
- Cancer Research 120
Countries citing papers authored by Philip Bonomi
This map shows the geographic impact of Philip Bonomi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Bonomi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Bonomi more than expected).
Fields of papers citing papers by Philip Bonomi
This network shows the impact of papers produced by Philip Bonomi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Bonomi. The network helps show where Philip Bonomi may publish in the future.
Co-authorship network of co-authors of Philip Bonomi
This figure shows the co-authorship network connecting the top 25 collaborators of Philip Bonomi. A scholar is included among the top collaborators of Philip Bonomi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Bonomi. Philip Bonomi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 89 | |
| 2 | 462 | |
| 3 | 1 | |
| 4 | Performans Statusu 2 Olan ve İleri Evre Küçük Hücreli Dışı Akciğer Kanseri Olgularında Kombinasyona Karşı Tek Ajan Kemoterapisi İki Büyük Randomize Klinik Çalışma Çerçevesinde Prognostik Faktörler ve Tedavi Seçimi | 1 |
| 5 | 25 | |
| 6 | 150 | |
| 7 | 93 | |
| 8 | 2 | |
| 9 | 1 | |
| 10 | 3 | |
| 11 | 7 | |
| 12 | Altered oncogene, tumor suppressor and cell-cycle gene expression in PANC-1 cells cultured with the pleiotrophic 5-lipoxygenase inhibitor, MK886, assessed with a gene chip. | 15 |
| 13 | 1 | |
| 14 | An in vivo inhibitor of 5-lipoxygenase, MK886, at micromolar concentration induces apoptosis in U937 and CML cells. | 44 |
| 15 | 4 | |
| 16 | 46 | |
| 17 | 27 | |
| 18 | 3 | |
| 19 | 51 | |
| 20 | Phase II trial of etoposide, cisplatin, continuous infusion 5-fluorouracil, and simultaneous split-course radiation therapy in stage III non-small-cell bronchogenic carcinoma. | 16 |
About Philip Bonomi
Philip Bonomi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Biophysics, having authored 37 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Research Studies (13 papers) and Cancer Treatment and Pharmacology (6 papers). The work is most often cited by research in Oncology (593 citations), Pulmonary and Respiratory Medicine (403 citations) and Molecular Biology (592 citations). Philip Bonomi has collaborated with scholars based in United States, United Kingdom and Ireland. Frequent co-authors include Sari H. Enschede, Charles M. Rudin, Geoffrey I. Shapiro, D. Gandara, Andrew Krivoshik, Philip M. Hemken, Christine L. Hann, Divis Khaira, Moacyr Oliveira and Leena Gandhi. Their work appears in journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.